Factor-specific generative pattern from large-scale drug-induced gene expression profile.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
18 04 2023
Historique:
received: 06 12 2022
accepted: 06 04 2023
medline: 20 4 2023
pubmed: 19 4 2023
entrez: 18 04 2023
Statut: epublish

Résumé

Drug discovery is a complex and interdisciplinary field that requires the identification of potential drug targets for specific diseases. In this study, we present FacPat, a novel approach that identifies the optimal factor-specific pattern explaining the drug-induced gene expression profile. FacPat uses a genetic algorithm based on pattern distance to mine the optimal factor-specific pattern for each gene in the LINCS L1000 dataset. We applied Benjamini-Hochberg correction to control the false discovery rate and identified significant and interpretable factor-specific patterns consisting of 480 genes, 7 chemical compounds, and 38 human cell lines. Using our approach, we identified genes that show context-specific effects related to chemical compounds and/or human cell lines. Furthermore, we performed functional enrichment analysis to characterize biological features. We demonstrate that FacPat can be used to reveal novel relationships among drugs, diseases, and genes.

Identifiants

pubmed: 37072452
doi: 10.1038/s41598-023-33061-x
pii: 10.1038/s41598-023-33061-x
pmc: PMC10113368
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6339

Informations de copyright

© 2023. The Author(s).

Références

Onco Targets Ther. 2019 Apr 02;12:2409-2419
pubmed: 31118659
Trends Neurosci. 1989 Nov;12(11):425-32
pubmed: 2479143
Front Genet. 2014 Sep 30;5:342
pubmed: 25324859
Mol Cancer Ther. 2003 Feb;2(2):151-63
pubmed: 12589032
Diagn Pathol. 2013 Aug 28;8:145
pubmed: 23984887
Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14621-6
pubmed: 20679242
Semin Cancer Biol. 2021 Jan;68:21-30
pubmed: 31562955
J Biol Chem. 2001 Jan 5;276(1):522-8
pubmed: 11016926
Mol Pharmacol. 2015 Aug;88(2):392-400
pubmed: 26048958
PLoS One. 2018 Aug 29;13(8):e0201937
pubmed: 30157183
J Surg Res. 2007 Oct;142(2):219-26
pubmed: 17612559
EMBO J. 2002 Dec 16;21(24):6820-31
pubmed: 12486003
Int J Mol Sci. 2017 Apr 27;18(5):
pubmed: 28448473
Front Pharmacol. 2020 Jan 29;10:1653
pubmed: 32063857
J Cell Biol. 1999 Dec 13;147(6):1167-80
pubmed: 10601332
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Bioinformatics. 2021 Jul 12;37(Suppl_1):i376-i382
pubmed: 34252937
Eur Urol. 2001 Aug;40(2):231-8
pubmed: 11528203
Cell. 2017 Nov 30;171(6):1437-1452.e17
pubmed: 29195078
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W449-60
pubmed: 24906883
Mol Cancer Res. 2021 Jan;19(1):3-13
pubmed: 32605929
Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5
pubmed: 23193258
Nature. 1981 Sep 10-16;293(5828):144-6
pubmed: 7266668
J Biomed Inform. 2007 Dec;40(6):787-802
pubmed: 17683991
Nucleic Acids Res. 2023 Jan 6;51(D1):D1257-D1262
pubmed: 36169237
Genes Dev. 2006 Sep 15;20(18):2566-79
pubmed: 16980585
Molecules. 2019 Aug 19;24(16):
pubmed: 31430892
Nucleic Acids Res. 2021 Jan 8;49(D1):D545-D551
pubmed: 33125081
Pflugers Arch. 2015 Dec;467(12):2401-11
pubmed: 26202611
Int J Cell Biol. 2011;2011:738301
pubmed: 21647292
Nucleic Acids Res. 2009 Jan;37(1):1-13
pubmed: 19033363
AAPS J. 2017 Sep;19(5):1264-1275
pubmed: 28577120
Sarcoma. 2011;2011:746939
pubmed: 21197471
J Comput Biol. 2000;7(3-4):559-83
pubmed: 11108479
Genome Biol. 2002;3(5):research0022
pubmed: 12049663
Protein Sci. 2019 Nov;28(11):1947-1951
pubmed: 31441146
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Biomed Res Int. 2019 Apr 07;2019:4256524
pubmed: 31080817
J Antibiot (Tokyo). 1976 Jan;29(1):1-6
pubmed: 931784
R Soc Open Sci. 2018 Nov 28;5(11):181321
pubmed: 30564416
Epigenetics. 2020 Jan - Feb;15(1-2):122-133
pubmed: 31423895
Exp Mol Med. 2006 Dec 31;38(6):616-24
pubmed: 17202837
Sci Rep. 2019 May 24;9(1):7849
pubmed: 31127155
J Immunol. 2006 Dec 1;177(11):8123-32
pubmed: 17114487
Am J Cancer Res. 2018 Nov 01;8(11):2227-2237
pubmed: 30555740
PLoS One. 2012;7(12):e51059
pubmed: 23284657

Auteurs

Se Hwan Ahn (SH)

Department of Biomedical Sciences, Seoul National University Biomedical Informatics (SNUBI), Seoul National University College of Medicine, Seoul, Republic of Korea.

Ju Han Kim (JH)

Department of Biomedical Sciences, Seoul National University Biomedical Informatics (SNUBI), Seoul National University College of Medicine, Seoul, Republic of Korea. juhan@snu.ac.kr.
Division of Biomedical Informatics, Seoul National University Biomedical Informatics (SNUBI), Seoul National University College of Medicine, Seoul, Republic of Korea. juhan@snu.ac.kr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH